ProfileGDS4132 / 203133_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 85% 89% 89% 89% 90% 90% 90% 92% 90% 87% 90% 90% 91% 93% 89% 89% 91% 97% 92% 89% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101318.15685
GSM201543Muscle PCOS pioglitazone 121377.25689
GSM201544Muscle PCOS pioglitazone 161445.38589
GSM201545Muscle PCOS pioglitazone 201444.74689
GSM201829Muscle PCOS pioglitazone 231454.02890
GSM201830Muscle PCOS pioglitazon 251436.8690
GSM201831Muscle PCOS pioglitazone 271434.85190
GSM201832Muscle PCOS pioglitazone 31523.57792
GSM201833Muscle PCOS pioglitazone 41425.84190
GSM201834Muscle PCOS pioglitazone 81383.75987
GSM201835Muscle PCOS after pioglitazone 102463.0290
GSM201836Muscle PCOS after pioglitazone 122463.67890
GSM201837Muscle PCOS after pioglitazone 162470.89791
GSM201838Muscle PCOS after pioglitazone 202659.93293
GSM201839Muscle PCOS after pioglitazone 232424.06689
GSM201840Muscle PCOS after pioglitazone 252445.46389
GSM201841Muscle PCOS after pioglitazone 272469.07291
GSM201842Muscle PCOS after pioglitazone 321267.497
GSM201843Muscle PCOS after pioglitazone 42560.03892
GSM201844Muscle PCOS after pioglitazone 82446.989